1. Home
  2. ELVA vs ENTX Comparison

ELVA vs ENTX Comparison

Compare ELVA & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVA
  • ENTX
  • Stock Information
  • Founded
  • ELVA 1996
  • ENTX 2010
  • Country
  • ELVA Canada
  • ENTX Israel
  • Employees
  • ELVA N/A
  • ENTX N/A
  • Industry
  • ELVA
  • ENTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ELVA
  • ENTX Health Care
  • Exchange
  • ELVA Nasdaq
  • ENTX Nasdaq
  • Market Cap
  • ELVA 125.5M
  • ENTX 104.0M
  • IPO Year
  • ELVA N/A
  • ENTX 2018
  • Fundamental
  • Price
  • ELVA $3.79
  • ENTX $1.80
  • Analyst Decision
  • ELVA Strong Buy
  • ENTX Strong Buy
  • Analyst Count
  • ELVA 5
  • ENTX 1
  • Target Price
  • ELVA $6.10
  • ENTX $10.00
  • AVG Volume (30 Days)
  • ELVA 77.3K
  • ENTX 35.1K
  • Earning Date
  • ELVA 08-12-2025
  • ENTX 08-08-2025
  • Dividend Yield
  • ELVA N/A
  • ENTX N/A
  • EPS Growth
  • ELVA N/A
  • ENTX N/A
  • EPS
  • ELVA N/A
  • ENTX N/A
  • Revenue
  • ELVA $48,016,000.00
  • ENTX $223,000.00
  • Revenue This Year
  • ELVA $55.29
  • ENTX N/A
  • Revenue Next Year
  • ELVA $63.69
  • ENTX N/A
  • P/E Ratio
  • ELVA N/A
  • ENTX N/A
  • Revenue Growth
  • ELVA N/A
  • ENTX N/A
  • 52 Week Low
  • ELVA $1.67
  • ENTX $1.41
  • 52 Week High
  • ELVA $3.89
  • ENTX $2.79
  • Technical
  • Relative Strength Index (RSI)
  • ELVA 67.50
  • ENTX 41.96
  • Support Level
  • ELVA $3.11
  • ENTX $1.72
  • Resistance Level
  • ELVA $3.89
  • ENTX $1.88
  • Average True Range (ATR)
  • ELVA 0.19
  • ENTX 0.11
  • MACD
  • ELVA 0.04
  • ENTX -0.02
  • Stochastic Oscillator
  • ELVA 94.23
  • ENTX 25.00

About ELVA Electrovaya Inc.

Electrovaya Inc designs develop and manufacture proprietary lithium-ion batteries, battery systems, and battery-related products for energy storage, clean electric transportation and other specialized applications. It is a technology-focused company with extensive IP. The company generates revenue from the sale of batteries and battery systems. Business operations are segmented based on large format batteries and others. This technology offers enhanced safety and battery longevity. Geographically it earns key revenue from the United States.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

Share on Social Networks: